RPCEC00000128已完成2 期
Evaluation of the effect and safety of sertraline in Cuban patients with major depressive disorder.
Dalhousie university, Halifax, Nova Scotia, Canada0 个研究点目标入组 82 人开始时间: 2012年5月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Pre-inclusion criteria Patients with major depressive disorder, diagnosed by DSM-IV. Patients with a value in the Hamilton Rating Scale for Depression (HAM-D) between 19 and 36 points inclusive. Patients of both sexes between 18 and 65, inclusive. Patients with capacity to consent for give their written consent to participate. 5. HCG (chorionic gonadotropin hormone) negative (for women of childbearing age). Inclusion criteria Patients whose score on the HAM-D at the end of the week pre-inclusion: • Do not change or, • Decrease less than 25% without being less than 19 points or, • It increases without exceeding 36 points. On the basis of physical examination, medical history, ECG, and the results of the tests: - Chemical Hematology: hemoglobin, hematocrit, total leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils and platelet count, creatinine, glucose, albumin, total bilirubin, alkaline phosphatase, SGPT and SGOT and cituria conducted in the pre-inclusion visit, the patient is, in the opinion of the investigator and according to normal laboratory healthy enough to enter the study.
排除标准
- •Psychiatric treatment of patients with minimal therapeutic dose in the two months prior to inclusion (depot neuroleptics, antidepressants, lithium, or carbamazepine valproates). Presence of other psychiatric disorder diagnosed or referred that explain the Depression: Bipolar Disorder, Schizophrenia or Mental Retardation. Patients at risk of suicide or attempted suicide in the last year or with scores between 3 and 4 in the suicide item of HAM-D. Patients with mental disorders due to brain injury or dysfunction or somatic illness. Patients with mental and behavioral disorders due to psychoactive substance use (alcohol, drugs, multiple drugs or other substances). Patients with altered renal or hepatic function. Pregnant women, nursing mothers, pregnant or not using effective contraception [IUDs in use at least 30 days before the start of the study, barrier methods (diaphragm plus spermicide, condom plus spermicide) to use at least 14 days before the start of the study or hormonal methods (oral contraceptives, implants)]. Patients resistant to treatment with the use of 2 or 3 SSRIs, MAOIs or TCAs at doses established and during the stipulated time. Patients requiring further treatment with use of psychotropic drugs, psychotherapeutic techniques such as general psychotherapy, cognitive-behavioral techniques, predisposition modification techniques, psychotherapy or other specific technical brief psychotherapy. Patients with hypersensitivity to sertraline. Patients who have failed to have been treated with sertraline on a previous occasion. Patients who have been participating in a clinical trial within 30 days prior to inclusion. Patients with unstable medical condition. Patients withconcomitant diseases requiring treatment with any of the following medications: MAOIs, lithium, warfarin, digitoxin, intravenous diazepam and tricyclic antidepressants.
研究者
相似试验
已完成
不适用
A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamineJPRN-UMIN000002654Hokkaido University Hospital, Department of Psychiatry140
招募中
2 期
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression levelIRCT20180425039418N4Zahedan University of Medical Sciences60
尚未招募
2 期
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3IRCT20100102002954N29Shahroud University of Medical Sciences82
尚未招募
3 期
Effect of Sertraline in treatment of Covid-19IRCT20220110053681N1Sabzevar University of Medical Sciences60
已完成
3 期
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying conditionIRCT20150630022991N9Babol University of Medical Sciences40